Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder.

[1]  A. McIntyre,et al.  A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder , 1993, European Neuropsychopharmacology.

[2]  D. Murphy,et al.  A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP , 1993, Biological Psychiatry.

[3]  P. Cowen,et al.  Fluoxetine and Suicidal Behaviour , 1992, British Journal of Psychiatry.

[4]  T. Dinan,et al.  Cortisol and Prolactin Responses to d-Fenfluramine in Non-depressed Patients with Obsessive-Compulsive Disorder: A Comparison with Depressed and Healthy Controls , 1992, British Journal of Psychiatry.

[5]  E. Smeraldi,et al.  5HT‐2 receptor and fluvoxamine effect in obsessive‐compulsive disorder , 1992 .

[6]  N. Fineberg,et al.  Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder , 1992, International clinical psychopharmacology.

[7]  S. Montgomery,et al.  Fluvoxamine in the treatment of obsessive compulsive disorder , 1992, International clinical psychopharmacology.

[8]  J. Csernansky,et al.  Fenfluramine stimulation of prolactin in obsessive-compulsive disorder , 1992, Psychiatry Research.

[9]  J. Sweeney,et al.  Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder , 1992, Biological Psychiatry.

[10]  J. Deakin.  Depression and 5HT , 1991, International clinical psychopharmacology.

[11]  S. Woods,et al.  Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects , 1991, Psychiatry Research.

[12]  M. Wiesmann,et al.  5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls. , 1991, Archives of general psychiatry.

[13]  H. Meltzer,et al.  Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder. , 1990, Archives of general psychiatry.

[14]  J. Krystal,et al.  Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. , 1990, Archives of general psychiatry.

[15]  S. Woods,et al.  Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. , 1988, Archives of general psychiatry.

[16]  P. Cowen,et al.  Neuroendocrine responses to intravenous tryptophan in major depression. , 1987, Archives of general psychiatry.

[17]  T. Insel,et al.  Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology , 1987, Biological Psychiatry.

[18]  T. Insel,et al.  Obsessive-compulsive disorder and serotonin: Is there a connection? , 1985, Biological Psychiatry.

[19]  D. Charney,et al.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.

[20]  M. Åsberg,et al.  Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. , 1980, Archives of general psychiatry.

[21]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[22]  E. Hollander,et al.  Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. , 1992, Archives of general psychiatry.

[23]  T. Dinan,et al.  Buspirone induced prolactin responses in obsessive‐compulsive disorder (OCD): is OCD a 5‐HT2 receptor disorder? , 1992, International clinical psychopharmacology.

[24]  J. Ananth,et al.  Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. , 1981, Progress in neuro-psychopharmacology.

[25]  M. Sa,et al.  Measurement of change in psychiatric illness: new obsessional, schizophrenia and depression scales. , 1980 .